Peri-implantitis Implantoplasty Treatment
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20+
SponsorUniversity of Oslo
About this trial
This double arm, split-mouth, single centre, controlled, randomised clinical study is designed to examine the effect of implantoplasty in treatment of peri-implantitis.
Peri-implantitis will be treated with open flap debridement, with or without implantoplasty.
Eligibility criteria
Qualifiers
Peri-implantitis (according to 2018 criteria) on minimum 2 implants of similar surface and defect type
Competent to give consent
Exposed, modified implant surface with loss >2mm
Disqualifiers
Previous radiotherapy to the jaws, current use of chemotherapy, systemic long-term corticosteroid treatment
Present or past use of bisphosphonate treatment • Pregnant or nursing subjects
Patients classified as > class II according to ASA classification
Implant unavailable for implantoplasty treatment
Trial design
Treatments tested in this trial
- Implantoplasty
- Open flap debridement alone
Treatment groups
35 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov